In the U.S., drugs cost approximately 2.5 times more than in other countries, with the price of new medications increasing by about 20% each year. However, studies have found no correlation between R&D costs and the launch price of drugs. Pharma companies argue that high prices fund future cures but some propose that companies are merely charging what the market can bear. Other countries negotiate drug prices based on clinical benefits, unlike the profit-driven U.S. model.
Cyber Threat Intelligence Review: Preparing for 2025
Cybersecurity threats are predicted to increase in 2025, with a rise in ransomware-as-a-service (RaaS), vulnerabilities in network edge devices, and misuse of AI. The growth
